Avoro Capital Advisors LLC Apellis Pharmaceuticals, Inc. Transaction History
Avoro Capital Advisors LLC
- $7.32 Billion
- Q3 2025
A detailed history of Avoro Capital Advisors LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 12,222,222 shares of APLS stock, worth $248 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
12,222,222
Previous 12,222,222
-0.0%
Holding current value
$248 Million
Previous $212 Million
30.73%
% of portfolio
3.78%
Previous 3.86%
Shares
12 transactions
Others Institutions Holding APLS
# of Institutions
328Shares Held
124MCall Options Held
4.12MPut Options Held
756K-
Vanguard Group Inc Valley Forge, PA9.99MShares$203 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.64MShares$196 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA9.29MShares$189 Million0.04% of portfolio
-
Deep Track Capital, LP Greenwich, CT8MShares$163 Million5.71% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$118 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.23B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...